Two types of PD-L1 expression in the tumour are known: an innate mechanism induced by genetic mutation and an adaptive mechanism induced by the stimulation of inflammatory cytokine, the latter of which is primarily caused by IFNγ [1]. The gene discussed is IFNG; the disease is neoplasm.